and CT/MRI/X-ray analysis/processing and identify research opportunities in the context of Digital Pathology and Radiology/COVID19.

AIMIA is jointly organised by INESCTEC (Portugal), NTUA (Greece), IMP Diagnostics (Portugal), Radboudumc (The Netherlands), Karolinska Institutet (Sweden), Google Health (USA) and the University

of Lincoln (UK). For more information please visit http://vcmi.inesctec.pt/aimia_eccv

***** IMPORTANT DATES *****

Submission deadline: July 08, 2022

Author notification: August 05, 2022

Camera-ready deadline: August 12, 2022 

AIMIA workshop: October 2022 (T.B.D.) 

***** KEYNOTE SPEAKERS *****

Dimitri Metaxas, Rutgers University, USA

Inti Zlobec, University of Bern, Switzerland

Henning Müller, HES-SO Vallais-Wallis, Switzerland

***** TOPICS OF INTEREST *****

The AIMIA workshop welcomes works that focus on (but are not limited to):

• Semi-/weakly-/self-supervised learning methodologies;

• Detection, classification and segmentation;

• Disease diagnosis, grading and prognosis;

• Treatment response prediction;

• Detection of tissue biomarkers with predictive/prognostic value;

• Image registration;

• Explainable AI;

• Clinical applications;

applied to Digital Pathology (TRACK A) and Radiology/COVID19 (TRACK B).

The workshop also invites submissions to the 2nd COV19D competition, organized within TRACK B: https://mlearn.lincoln.ac.uk/eccv-2022-ai-mia/

Submitted manuscripts should be anonymised and formatted according to the ECCV style, with a maximum of 14 pages, including images and tables and excluding cited references.

Accepted papers will be published in Springer, as part of the ECCV 2022 proceedings (workshops set).

Do you want to submit your work? Please access https://cmt3.research.microsoft.com/AIMIA2022.

***** CONTACTS *****

Jaime Cardoso (jaime.cardoso@inesctec.pt)